NEW YORK, April 01, 2026 (GLOBE NEWSWIRE)-- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell ...
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE)-- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company dedicated to advancing precision nerve-targeted ...
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell ...
Google's Agent Development Kit for Java reached 1.0, introducing integrations with new external tools, a new app and plugin ...